For the first time, New England’s largest biotechnology investor forum has invited disease foundations and government grant programs to connect with the event’s traditional audiences — venture capitalists and other investment professionals, and local public and private companies. The MassBIO Investors Forum will feature a full day of programs, including expert panel discussions, individual company presentations and one-on-one meetings.